Performance of NTLA Intellia Therapeutics | -40.1% in 12m
Compare NTLA with Indices, Sectors and Commodities ✔ like Oil, Gas, Gold, Yields and Bonds. Who outperforms?
Compare Intellia Therapeutics with its related Sector/Index XBI
Performance Duell NTLA vs XBI
| TimeFrame | NTLA | XBI |
|---|---|---|
| 1 Day | 0.19% | -1.52% |
| 1 Week | 7.20% | 3.45% |
| 1 Month | 22.0% | 7.71% |
| 3 Months | -5.48% | -2.11% |
| 6 Months | -6.76% | 25.51% |
| 12 Months | -40.1% | 6.37% |
| YTD | -14.9% | 1.05% |
| Rel. Perf. 1m | 1.03 | |
| Rel. Perf. 3m | -1.61 | |
| Rel. Perf. 6m | -2.65 | |
| Rel. Perf. 12m | -5.85 |
Is Intellia Therapeutics a good stock to buy?
No, based on ValueRay Fundamental Analyses, Intellia Therapeutics (NASDAQ:NTLA) is currently (May 2024)
a stock to sell. It has a ValueRay Fundamental Rating of -72.93 and therefor a negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of NTLA as of May 2024 is 22.13. This means that NTLA is currently overvalued and has a potential downside of -15.6% (Sold with Premium).
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of NTLA as of May 2024 is 22.13. This means that NTLA is currently overvalued and has a potential downside of -15.6% (Sold with Premium).
Is NTLA a buy, sell or hold?
Intellia Therapeutics has no consensus analysts rating. ValueRay therefore judges the recommendation based on the last 12 Month Returns of -40.14%.
In compare to SPDR S&P Biotech, NTLA made -46.51% less over the last 12 months. Due to the underperformance, it is recommend to sell NTLA.
In compare to SPDR S&P Biotech, NTLA made -46.51% less over the last 12 months. Due to the underperformance, it is recommend to sell NTLA.
Values above 0%: NTLA is performing better - Values below 0%: NTLA is underperforming
Compare NTLA with Broad Market Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 5.55% | 16.18% | -25.05% | -69.49% |
| US NASDAQ 100 | QQQ | 5.01% | 15.86% | -24.23% | -77.49% |
| US Dow Jones Industrial 30 | DIA | 5.84% | 15.78% | -22.23% | -62.16% |
| German DAX 40 | DBXD | 7.60% | 16.98% | -23.75% | -56.91% |
| UK FTSE 100 | ISFU | 5.70% | 12.15% | -23.62% | -55.51% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 6.09% | 17.43% | -10.09% | -32.47% |
| Hongkong Hang Seng | HSI | 3.47% | -1.33% | -11.80% | -34.78% |
| Japan Nikkei 225 | EXX7 | 6.83% | 22.45% | -18.25% | -51.95% |
| India NIFTY 50 | INDA | 4.09% | 18.03% | -24.34% | -68.86% |
| Brasil Bovespa | EWZ | 6.76% | 16.71% | -4.93% | -52.47% |
NTLA Intellia Therapeutics vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 6.20% | 18.64% | -25.27% | -77.62% |
| Consumer Discretionary | XLY | 6.86% | 18.25% | -14.10% | -59.81% |
| Consumer Staples | XLP | 6.44% | 15.37% | -21.00% | -45.72% |
| Energy | XLE | 6.00% | 21.07% | -20.88% | -65.36% |
| Financial | XLF | 5.62% | 14.90% | -29.18% | -73.21% |
| Health Care | XLV | 5.31% | 16.27% | -21.77% | -53.64% |
| Industrial | XLI | 7.48% | 18.47% | -26.45% | -68.47% |
| Materials | XLB | 6.86% | 18.41% | -22.78% | -60.76% |
| Real Estate | XLRE | 4.69% | 13.47% | -16.40% | -50.12% |
| Technology | XLK | 4.14% | 15.43% | -23.08% | -78.45% |
| Utilities | XLU | 5.70% | 9.06% | -24.96% | -52.82% |
| Aerospace & Defense | XAR | 6.43% | 13.49% | -22.30% | -64.29% |
| Biotech | XBI | 3.75% | 14.24% | -32.27% | -46.51% |
| Homebuilder | XHB | 7.52% | 15.61% | -37.27% | -90.99% |
| Retail | XRT | 5.12% | 14.49% | -27.60% | -65.33% |
Does Intellia Therapeutics outperform its market, is NTLA a Sector Leader?
No, over the last 12 months Intellia Therapeutics (NTLA) made -40.14%, while its related Sector, the SPDR S&P Biotech (XBI) made 6.37%.
Over the last 3 months NTLA made -5.48%, while XBI made -2.11%.
No, over the last 12 months Intellia Therapeutics (NTLA) made -40.14%, while its related Sector, the SPDR S&P Biotech (XBI) made 6.37%.
Over the last 3 months NTLA made -5.48%, while XBI made -2.11%.
| Period | NTLA | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 21.95% | 7.71% | 5.77% |
| 3 Months | -5.48% | -2.11% | 6.32% |
| 12 Months | -40.14% | 6.37% | 29.35% |